1. Home
  2. RCMT vs NKTX Comparison

RCMT vs NKTX Comparison

Compare RCMT & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCMT
  • NKTX
  • Stock Information
  • Founded
  • RCMT 1971
  • NKTX 2015
  • Country
  • RCMT United States
  • NKTX United States
  • Employees
  • RCMT N/A
  • NKTX N/A
  • Industry
  • RCMT Professional Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCMT Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • RCMT Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • RCMT 165.8M
  • NKTX 170.8M
  • IPO Year
  • RCMT N/A
  • NKTX 2020
  • Fundamental
  • Price
  • RCMT $15.86
  • NKTX $2.00
  • Analyst Decision
  • RCMT Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • RCMT 2
  • NKTX 6
  • Target Price
  • RCMT $33.50
  • NKTX $15.00
  • AVG Volume (30 Days)
  • RCMT 57.6K
  • NKTX 2.4M
  • Earning Date
  • RCMT 03-12-2025
  • NKTX 03-26-2025
  • Dividend Yield
  • RCMT N/A
  • NKTX N/A
  • EPS Growth
  • RCMT N/A
  • NKTX N/A
  • EPS
  • RCMT 1.68
  • NKTX N/A
  • Revenue
  • RCMT $278,380,000.00
  • NKTX N/A
  • Revenue This Year
  • RCMT $14.90
  • NKTX N/A
  • Revenue Next Year
  • RCMT N/A
  • NKTX N/A
  • P/E Ratio
  • RCMT $9.44
  • NKTX N/A
  • Revenue Growth
  • RCMT 5.75
  • NKTX N/A
  • 52 Week Low
  • RCMT $13.18
  • NKTX $1.31
  • 52 Week High
  • RCMT $26.37
  • NKTX $11.84
  • Technical
  • Relative Strength Index (RSI)
  • RCMT 40.04
  • NKTX 59.36
  • Support Level
  • RCMT $14.83
  • NKTX $1.31
  • Resistance Level
  • RCMT $16.01
  • NKTX $2.34
  • Average True Range (ATR)
  • RCMT 0.97
  • NKTX 0.15
  • MACD
  • RCMT 0.05
  • NKTX 0.05
  • Stochastic Oscillator
  • RCMT 54.47
  • NKTX 66.99

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Engineering, which provides a comprehensive portfolio of engineering and design services across three verticals: Energy Services, Process & Industrial, and Aerospace, Life Sciences and Information Technology and Specialty Health Care Services, engaged in providing the staffing of health care professionals, primarily health information management professionals, nurses, paraprofessionals, physicians. The company generates maximum revenue from the Specialty Health Care segment. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Puerto Rico, and Serbia.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: